A Novel C Type CpG Oligodeoxynucleotide Exhibits Immunostimulatory Activity In Vitro and Enhances Antitumor Effect In Vivo
BackgroundC type CpG oligodeoxynucleotides (CpG-C ODNs), possessing the features of both A type and B type CpG ODNs, exert a variety of immunostimulatory activities and have been demonstrated as an effective antitumor immunotherapy. Based on the structural characteristics, we designed 20 potential O...
שמור ב:
Main Authors: | Tete Li (Author), Jing Wu (Author), Shan Zhu (Author), Guoxia Zang (Author), Shuang Li (Author), Xinping Lv (Author), Wenjun Yue (Author), Yuan Qiao (Author), Jiuwei Cui (Author), Yan Shao (Author), Jun Zhang (Author), Yong-Jun Liu (Author), Jingtao Chen (Author) |
---|---|
פורמט: | ספר |
יצא לאור: |
Frontiers Media S.A.,
2020-02-01T00:00:00Z.
|
נושאים: | |
גישה מקוונת: | Connect to this object online. |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
פריטים דומים
-
CpG Oligodeoxynucleotides for Anticancer Monotherapy from Preclinical Stages to Clinical Trials
מאת: Zhongkun Zhang, et al.
יצא לאור: (2021) -
CpG immunostimulatory oligodeoxynucleotide 1826 as a novel nasal ODN adjuvant enhanced the protective efficacy of the periodontitis gene vaccine in a periodontitis model in SD rats
מאת: Guohui Bai, et al.
יצא לאור: (2021) -
Co-Encapsulated CpG Oligodeoxynucleotides and Ovalbumin in PLGA Microparticles; An in vitro and in vivo Study
מאת: Beatriz San Román, et al.
יצא לאור: (2014) -
CpG Oligodeoxynucleotide Developed to Activate Primate Immune Responses Promotes Antitumoral Effects in Combination with a Neoantigen-Based mRNA Cancer Vaccine
מאת: Li Q, et al.
יצא לאור: (2021) -
Cooperative activation of human TLR9 and consequences for the clinical development of antisense and CpG oligodeoxynucleotides
מאת: Gunther Hartmann
יצא לאור: (2023)